For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240521:nRSU3564Pa&default-theme=true
RNS Number : 3564P Judges Scientific PLC 21 May 2024
21 May 2024
Judges Scientific plc
(the "Group" or "Judges")
Result of Annual General Meeting and General Meeting
Judges Scientific (AIM: JDG), a group focused on acquiring and developing
companies in the scientific instrument sector, announces that, at the Annual
General Meeting ("AGM") held earlier today, all of the resolutions put to
shareholders were duly passed. In addition, at the General Meeting held
immediately after the AGM, all of the resolutions put to shareholders were
duly passed.
The votes received at the AGM are detailed below:
Resolution Votes for % Discretion % Votes against % Votes withheld
Resolution 1 (Ordinary) 3,175,302 99.37 19,890 0.62 16 0.01 3,035
To receive and, if approved, adopt the audited financial statements of the
Company for the year ended 31 December 2023 and the reports of the Directors
and auditor thereon.
Resolution 2 (Ordinary) 3,067,573 95.93 19,890 0.62 110,354 3.45 426
To approve both the Remuneration Policy and the Remuneration Report (other
than the part containing the Remuneration Policy) as respectively set out in
the Annual Report and Accounts 2023.
Resolution 3 (Ordinary) 3,130,448 97.88 19,890 0.62 47,840 1.5 65
To re-appoint Susan Nyman, who was appointed by the Board on 21 November 2023,
as a Director.
Resolution 4 (Ordinary) 2,895,942 90.55 19,890 0.62 282,374 8.83 37
To re-appoint Hon. Alexander Hambro, who retires by rotation, as a Director.
Resolution 5 (Ordinary) 3,064,925 95.83 19,890 0.62 113,404 3.55 24
To re-appoint Bradley Ormsby, who retires by rotation, as a Director.
Resolution 6 (Ordinary) 3,031,351 94.78 19,890 0.62 146,978 4.6 24
To re-appoint Mark Lavelle, who retires by rotation, as a Director.
Resolution 7 (Ordinary) 3,105,732 97.11 19,890 0.62 72,556 2.27 65
To re-appoint Lushani Kodituwakku, who retires by rotation, as a Director.
Resolution 8 (Ordinary) 3,177,889 99.37 19,890 0.62 459 0.01 5
To approve a final dividend of 68.0p per Ordinary share.
Resolution 9 (Ordinary) 3,178,053 99.37 19,890 0.62 222 0.01 78
To approve the re-appointment of BDO UK LLP as auditor to hold office formally
from the conclusion of this meeting until the conclusion of the next
Resolution 10 (Special) 3,169,725 99.12 19,890 0.62 8,185 0.26 443
To authorise the directors to allot relevant securities
Resolution 11 (Special) 2,781,412 86.98 19,890 0.62 396,464 12.4 477
To disapply pre-emption rights
Resolution 12 (Special) 3,106,989 99.28 19,890 0.64 2,385 0.08 68,979
To resolve that the company be and is unconditionally authorised to make
market purchases
The votes received at the General Meeting are detailed below:
Resolution Votes for % Discretion % Votes against % Votes withheld
Resolution 1 (Special) 2,626,744 99.98 40 0.01 43 0.01 584
THAT article 21 of the Company's articles of association (the Articles) shall
be deleted and replaced by inserting a new article 21
Resolution 2 (Special) 2,626,757 99.98 40 0.01 30 0.01 584
THAT article 22.5(a) of the Articles shall be amended to delete the words "by
rotation or otherwise".
Resolution 3 (Special) 2,626,394 99.98 40 0.01 43 0.01 934
THAT article 26.2 of the Articles shall be amended to delete the words "by
rotation"
Resolution 4 (Ordinary) 2,535,410 96.51 40 0.01 91,436 3.48 525
To re-appoint David Cicurel, who retires annually, as a Director.
Resolution 5 (Ordinary) 2,532,678 96.41 40 0.01 94,168 3.58 525
To re-appoint Tim Prestidge, who retires annually, as a Director.
Resolution 6 (Ordinary) 1,483,520 56.47 40 0.01 1,143,326 43.52 525
To re-appoint Ralph Elman, who retires annually, as a Director.
Resolution 7 (Ordinary) 2,412,756 96.03 40 0.01 99,542 3.96 115,073
To re-appoint Charles Holroyd, who retires annually, as a Director.
The Board notes that more than 20% of shareholders voted against resolution
six at the General Meeting. The Board intends to consult with shareholders
to understand their views.
Details of the votes cast on all resolutions will also be available on the
Company's website: www.judges.uk.com.
- Ends -
For further information please contact:
Judges Scientific plc Shore Capital (Nominated Adviser & Joint Broker)
David Cicurel, CEO Stephane Auton
Brad Ormsby, CFO Harry Davies-Ball
Tel: +44 (0) 20 3829 6970 Tel: +44 (0) 20 7408 4090
Liberum (Joint Broker) Investec Bank plc (Joint Broker)
Edward Mansfield Virginia Bull
Nikhil Varghese Carlton Nelson
Tel : +44 (0) 20 3100 2222 Tel: +44 (0) 207 597 4000
Alma (Financial Public Relations)
Sam Modlin
Rebecca Sanders-Hewett
Joe Pederzolli
Tel: +44 (0) 20 3405 0205
judges@almastrategic.com
Notes to editors:
Judges Scientific plc (AIM: JDG), is a group focused on acquiring and
developing companies in the scientific instrument sector. The Group now
consists of 23 businesses acquired since 2005.
The acquired companies are primarily UK-based with products sold worldwide to
a diverse range of markets including: higher education institutions,
scientific research facilities, manufacturers and regulatory authorities.
The UK is a recognised centre of excellence for scientific instruments.
The Group has received five Queen's Awards for innovation and export.
The Group's companies predominantly operate in global niche markets, with long
term growth fundamentals and resilient margins.
Judges Scientific maintains a policy of selectively acquiring businesses that
generate sustainable profits and cash. Shareholder returns are created
through the reduction of debt, organic growth and dividends.
For further information, please visit www.judges.uk.com
(https://url.avanan.click/v2/___http:/www.judges.uk.com/___.YXAxZTpzaG9yZWNhcDphOm86M2M4NzY3NGU5MjMxNzExOWZjYjg5ODlkYjkxNmZmZDI6NjoxMTMwOjk3ZWNjN2I3YmJmODJiYTYyYzE0NjI5NzI5NzQzMTEzY2NkOWJlMDYxNWM5OTcyYTU2YmJhNGU0NDYyNGRkNzI6cDpU)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ROMABMFTMTTTBAI